Zimmermann, Julie http://orcid.org/0000-0001-6442-6439
van Haren, Simon D. http://orcid.org/0000-0002-1791-0161
Diray-Arce, Joann
Adriawan, Ignatius Ryan
Wørzner, Katharina http://orcid.org/0000-0002-9430-4229
Krog, Ricki T. http://orcid.org/0000-0002-0201-7207
Guleed, Safia
Hu, Tu
Mortensen, Rasmus http://orcid.org/0000-0003-0177-3032
Dietrich, Jes http://orcid.org/0000-0001-8536-0141
Solbak, Sara M. Ø.
Levy, Ofer http://orcid.org/0000-0002-5859-1945
Christensen, Dennis http://orcid.org/0000-0003-2382-8639
Pedersen, Gabriel K. http://orcid.org/0000-0001-6872-3975
Funding for this research was provided by:
European Commission (2011.1.4-4-280873)
U.S. Department of Health & Human Services | National Institutes of Health (9686 6269, 9686 6269, 9686 6269)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93019C00044, HHSN272201800047C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 16 June 2023
Accepted: 22 November 2023
First Online: 22 December 2023
Change Date: 11 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-024-00804-4
Competing interests
: G.K.P., J.D., S.G., K.W., J.Z. are employed by Statens Serum Institut, which is a non-profit government research facility, holding patents on the cationic adjuvant formulations (CAF®). D.C. is currently employed by CRODA Pharma. O.L. and S.D.v.H. have received a sponsored research agreement from GlaxoSmithKline (GSK). O.L. has provided expert consulting to GSK and Takeda.